A Systematic Examination of the 2013 ACC/AHA Pooled Cohort Risk Assessment Tool for Atherosclerotic Cardiovascular Disease

Abstract Background The 2013 American College of Cardiology/American Heart Association updated cholesterol guidelines recommend the use of Pooled Cohort Equations to estimate 10-year absolute risk for atherosclerotic cardiovascular disease (ASCVD) in primary prevention. Objectives This study sought...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 64; no. 10; pp. 959 - 968
Main Authors Karmali, Kunal N., MD, Goff, David C., MD, PhD, Ning, Hongyan, MD, Lloyd-Jones, Donald M., MD, ScM
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 09.09.2014
Elsevier
Elsevier Limited
Subjects
SBP
CVD
CHD
Online AccessGet full text

Cover

Loading…
Abstract Abstract Background The 2013 American College of Cardiology/American Heart Association updated cholesterol guidelines recommend the use of Pooled Cohort Equations to estimate 10-year absolute risk for atherosclerotic cardiovascular disease (ASCVD) in primary prevention. Objectives This study sought to systematically examine the Pooled Cohort Equations to determine risk factor levels required to exceed risk thresholds outlined in new cholesterol guidelines. Methods We entered continuous risk factor levels in isolation and in specified combinations with the risk tool, and we observed predicted risk output patterns. We used the 10-year ASCVD risk threshold of ≥7.5% as a clinically relevant risk threshold. Results We demonstrated that a hypothetical man or woman can reach clinically relevant risk thresholds throughout the eligible age spectrum of 40 to 79 years of age, depending on the associated risk factor burden in all race-sex groups. Age continues to be a major determinant of 10-year ASCVD risk for both men and women. Compared with the previous risk assessment tool used in cholesterol guidelines, the inclusion of a stroke endpoint and use of race-specific coefficients permit identification of at-risk African Americans and non-Hispanic white women at much younger ages and lower risk factor levels. Conclusions These data provide context of specific risk factor levels and groups of individuals who are likely to have 10-year ASCVD risk estimates ≥7.5%. Age continues to be a major driver of risk, which highlights the importance of the clinician-patient discussion before statin therapy is initiated.
AbstractList The 2013 American College of Cardiology/American Heart Association updated cholesterol guidelines recommend the use of Pooled Cohort Equations to estimate 10-year absolute risk for atherosclerotic cardiovascular disease (ASCVD) in primary prevention. This study sought to systematically examine the Pooled Cohort Equations to determine risk factor levels required to exceed risk thresholds outlined in new cholesterol guidelines. We entered continuous risk factor levels in isolation and in specified combinations with the risk tool, and we observed predicted risk output patterns. We used the 10-year ASCVD risk threshold of ≥7.5% as a clinically relevant risk threshold. We demonstrated that a hypothetical man or woman can reach clinically relevant risk thresholds throughout the eligible age spectrum of 40 to 79 years of age, depending on the associated risk factor burden in all race-sex groups. Age continues to be a major determinant of 10-year ASCVD risk for both men and women. Compared with the previous risk assessment tool used in cholesterol guidelines, the inclusion of a stroke endpoint and use of race-specific coefficients permit identification of at-risk African Americans and non-Hispanic white women at much younger ages and lower risk factor levels. These data provide context of specific risk factor levels and groups of individuals who are likely to have 10-year ASCVD risk estimates ≥7.5%. Age continues to be a major driver of risk, which highlights the importance of the clinician-patient discussion before statin therapy is initiated.
BACKGROUNDThe 2013 American College of Cardiology/American Heart Association updated cholesterol guidelines recommend the use of Pooled Cohort Equations to estimate 10-year absolute risk for atherosclerotic cardiovascular disease (ASCVD) in primary prevention.OBJECTIVESThis study sought to systematically examine the Pooled Cohort Equations to determine risk factor levels required to exceed risk thresholds outlined in new cholesterol guidelines.METHODSWe entered continuous risk factor levels in isolation and in specified combinations with the risk tool, and we observed predicted risk output patterns. We used the 10-year ASCVD risk threshold of ≥7.5% as a clinically relevant risk threshold.RESULTSWe demonstrated that a hypothetical man or woman can reach clinically relevant risk thresholds throughout the eligible age spectrum of 40 to 79 years of age, depending on the associated risk factor burden in all race-sex groups. Age continues to be a major determinant of 10-year ASCVD risk for both men and women. Compared with the previous risk assessment tool used in cholesterol guidelines, the inclusion of a stroke endpoint and use of race-specific coefficients permit identification of at-risk African Americans and non-Hispanic white women at much younger ages and lower risk factor levels.CONCLUSIONSThese data provide context of specific risk factor levels and groups of individuals who are likely to have 10-year ASCVD risk estimates ≥7.5%. Age continues to be a major driver of risk, which highlights the importance of the clinician-patient discussion before statin therapy is initiated.
The 2013 American College of Cardiology/American Heart Association updated cholesterol guidelines recommend the use of Pooled Cohort Equations to estimate 10-year absolute risk for atherosclerotic cardiovascular disease (ASCVD) in primary prevention. This study sought to systematically examine the Pooled Cohort Equations to determine risk factor levels required to exceed risk thresholds outlined in new cholesterol guidelines. We entered continuous risk factor levels in isolation and in specified combinations with the risk tool, and we observed predicted risk output patterns. We used the 10-year ASCVD risk threshold of ≥7.5% as a clinically relevant risk threshold. We demonstrated that a hypothetical man or woman can reach clinically relevant risk thresholds throughout the eligible age spectrum of 40 to 79 years of age, depending on the associated risk factor burden in all race-sex groups. Age continues to be a major determinant of 10-year ASCVD risk for both men and women. Compared with the previous risk assessment tool used in cholesterol guidelines, the inclusion of a stroke endpoint and use of race-specific coefficients permit identification of at-risk African Americans and non-Hispanic white women at much younger ages and lower risk factor levels. These data provide context of specific risk factor levels and groups of individuals who are likely to have 10-year ASCVD risk estimates ≥7.5%. Age continues to be a major driver of risk, which highlights the importance of the clinician-patient discussion before statin therapy is initiated.
Background The 2013 American College of Cardiology/American Heart Association updated cholesterol guidelines recommend the use of Pooled Cohort Equations to estimate 10-year absolute risk for atherosclerotic cardiovascular disease (ASCVD) in primary prevention. Objectives This study sought to systematically examine the Pooled Cohort Equations to determine risk factor levels required to exceed risk thresholds outlined in new cholesterol guidelines. Methods We entered continuous risk factor levels in isolation and in specified combinations with the risk tool, and we observed predicted risk output patterns. We used the 10-year ASCVD risk threshold of >=7.5% as a clinically relevant risk threshold. Results We demonstrated that a hypothetical man or woman can reach clinically relevant risk thresholds throughout the eligible age spectrum of 40 to 79 years of age, depending on the associated risk factor burden in all race-sex groups. Age continues to be a major determinant of 10-year ASCVD risk for both men and women. Compared with the previous risk assessment tool used in cholesterol guidelines, the inclusion of a stroke endpoint and use of race-specific coefficients permit identification of at-risk African Americans and non-Hispanic white women at much younger ages and lower risk factor levels. Conclusions These data provide context of specific risk factor levels and groups of individuals who are likely to have 10-year ASCVD risk estimates >=7.5%. Age continues to be a major driver of risk, which highlights the importance of the clinician-patient discussion before statin therapy is initiated.
Abstract Background The 2013 American College of Cardiology/American Heart Association updated cholesterol guidelines recommend the use of Pooled Cohort Equations to estimate 10-year absolute risk for atherosclerotic cardiovascular disease (ASCVD) in primary prevention. Objectives This study sought to systematically examine the Pooled Cohort Equations to determine risk factor levels required to exceed risk thresholds outlined in new cholesterol guidelines. Methods We entered continuous risk factor levels in isolation and in specified combinations with the risk tool, and we observed predicted risk output patterns. We used the 10-year ASCVD risk threshold of ≥7.5% as a clinically relevant risk threshold. Results We demonstrated that a hypothetical man or woman can reach clinically relevant risk thresholds throughout the eligible age spectrum of 40 to 79 years of age, depending on the associated risk factor burden in all race-sex groups. Age continues to be a major determinant of 10-year ASCVD risk for both men and women. Compared with the previous risk assessment tool used in cholesterol guidelines, the inclusion of a stroke endpoint and use of race-specific coefficients permit identification of at-risk African Americans and non-Hispanic white women at much younger ages and lower risk factor levels. Conclusions These data provide context of specific risk factor levels and groups of individuals who are likely to have 10-year ASCVD risk estimates ≥7.5%. Age continues to be a major driver of risk, which highlights the importance of the clinician-patient discussion before statin therapy is initiated.
Author Ning, Hongyan, MD
Lloyd-Jones, Donald M., MD, ScM
Karmali, Kunal N., MD
Goff, David C., MD, PhD
Author_xml – sequence: 1
  fullname: Karmali, Kunal N., MD
– sequence: 2
  fullname: Goff, David C., MD, PhD
– sequence: 3
  fullname: Ning, Hongyan, MD
– sequence: 4
  fullname: Lloyd-Jones, Donald M., MD, ScM
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28779772$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/25190228$$D View this record in MEDLINE/PubMed
BookMark eNqFUl1rFDEUDVKx2-ovECQggi-7zeck86AwjNUKBcXW55DJ3KHZzkxqMlvcB_9Lf0t_mRl3tdAXX5IL95xzP849QgdjGAGhl5SsKKHFyXq1ts6tGKFiRYoVpbp4ghZUSr3kslQHaEEUl0tKSnWIjlJaE0IKTctn6JBJWhLG9AL9qvDFNk0w2Mk7fPrTDn7MYRhx6PB0BTjL8_u7qq5PqrMKfw2hhxbX4SrECX_z6TrnUoKUBhgnfJnTuAsRV5kaQ3J9frPw_V1tY-vDrU1u09uIP_gENsFz9LSzfYIX-_8Yff94elmfLc-_fPpcV-dLJ6malrS0pSqFUo1ijWx4jgUHLonj0DDRMC20EIUsnJWd6oRT1nVtq7Ul0Miu5cfo7U73JoYfG0iTGXxy0Pd2hLBJhsqCSM2I5Bn6-hF0HTZxzN0ZWhSaCMkUyyi-Q7k8ZYrQmZvoBxu3hhIzu2PWZnbHzO4YUpjZncx6tdfeNAO0_zh_7ciAN3tAXpTtu2hH59MDTitVqj_l3-1wkJd26yGa5DyMDlofwU2mDf4_jbx_xHe9H30ueQ1bSA8Tm8QMMRfzIc13RAURmirFfwN5UsV-
CODEN JACCDI
CitedBy_id crossref_primary_10_1155_2017_6913106
crossref_primary_10_1093_ajh_hpaa099
crossref_primary_10_1016_j_jcct_2015_09_003
crossref_primary_10_1002_14651858_CD002752_pub4
crossref_primary_10_1016_j_jacl_2015_06_007
crossref_primary_10_1016_j_jacc_2017_05_037
crossref_primary_10_1007_s11883_023_01104_3
crossref_primary_10_1007_s10900_019_00646_5
crossref_primary_10_1007_s40256_015_0111_x
crossref_primary_10_21763_tjfmpc_798484
crossref_primary_10_1002_nau_24325
crossref_primary_10_1161_JAHA_116_005054
crossref_primary_10_1007_s00345_016_1912_5
crossref_primary_10_1038_s41569_021_00638_w
crossref_primary_10_4103_jrms_jrms_318_23
crossref_primary_10_1186_s12872_021_02149_5
crossref_primary_10_1016_j_jcmg_2020_11_013
crossref_primary_10_3389_fcvm_2022_855390
crossref_primary_10_1161_JAHA_115_001888
crossref_primary_10_1161_CIR_0000000000000558
crossref_primary_10_1080_10641963_2023_2271190
crossref_primary_10_1161_CIR_0000000000000950
crossref_primary_10_1159_000485659
crossref_primary_10_1016_j_jacc_2016_02_055
crossref_primary_10_1161_CIR_0000000000000678
crossref_primary_10_1007_s11886_022_01751_z
crossref_primary_10_1016_j_jsha_2016_06_002
crossref_primary_10_1097_MJT_0000000000000185
crossref_primary_10_1136_bmj_n776
crossref_primary_10_1016_j_ajpc_2023_100612
crossref_primary_10_1016_j_cjca_2014_11_007
crossref_primary_10_1002_clc_23427
crossref_primary_10_1093_eurheartj_ehv182
crossref_primary_10_1016_j_clml_2021_04_014
crossref_primary_10_1016_j_jacc_2019_03_010
crossref_primary_10_1016_j_mayocp_2021_08_027
crossref_primary_10_18332_tid_118232
crossref_primary_10_1016_j_berh_2019_01_002
crossref_primary_10_1161_CIR_0000000000000485
crossref_primary_10_1016_j_jacc_2019_02_057
crossref_primary_10_3389_fphar_2020_594474
crossref_primary_10_3899_jrheum_171196
crossref_primary_10_1016_j_jpsychores_2022_110920
crossref_primary_10_1016_j_atherosclerosis_2015_03_006
crossref_primary_10_1111_jnu_12465
crossref_primary_10_1080_14737159_2024_2306127
crossref_primary_10_1038_s41598_021_01213_6
crossref_primary_10_1016_j_puhe_2021_06_001
crossref_primary_10_1007_s12170_015_0455_4
crossref_primary_10_1016_j_jcmg_2018_07_035
crossref_primary_10_1016_j_rccl_2019_01_024
crossref_primary_10_3390_ijerph13111093
crossref_primary_10_1002_hec_4569
crossref_primary_10_1161_CIR_0000000000000659
crossref_primary_10_1007_s11606_015_3556_3
crossref_primary_10_1002_art_40925
crossref_primary_10_1001_jama_2023_7575
crossref_primary_10_1016_j_jacc_2019_04_049
crossref_primary_10_1016_j_jacadv_2022_100003
crossref_primary_10_1161_CIR_0000000000001077
crossref_primary_10_1016_j_jacc_2018_08_1041
crossref_primary_10_1093_rheumatology_kez429
crossref_primary_10_1016_j_puhe_2023_12_010
crossref_primary_10_1161_CIRCULATIONAHA_116_024436
crossref_primary_10_1016_j_nefro_2016_10_002
crossref_primary_10_1161_CIR_0000000000000624
crossref_primary_10_1161_CIR_0000000000000625
crossref_primary_10_1016_j_nefroe_2017_03_005
crossref_primary_10_1038_s41598_020_75314_z
crossref_primary_10_1186_s12889_020_08472_4
crossref_primary_10_1001_jama_2019_21782
crossref_primary_10_1016_j_ejim_2023_02_001
crossref_primary_10_1007_s12410_017_9431_3
crossref_primary_10_1016_j_jcct_2023_04_004
crossref_primary_10_1016_j_jacc_2023_03_401
crossref_primary_10_1016_j_mehy_2018_10_026
crossref_primary_10_1038_s41598_023_40820_3
crossref_primary_10_3389_fcvm_2023_1161761
crossref_primary_10_1016_j_ijcard_2017_09_196
crossref_primary_10_1016_j_jacc_2022_05_015
crossref_primary_10_1016_j_arres_2021_100022
crossref_primary_10_1016_j_bbadis_2018_06_011
crossref_primary_10_1016_j_jacc_2014_12_021
crossref_primary_10_1161_CIRCULATIONAHA_123_067626
crossref_primary_10_1016_j_healthpol_2016_05_009
crossref_primary_10_1016_j_jacl_2015_11_006
crossref_primary_10_1038_s41591_024_02905_y
crossref_primary_10_1161_CIR_0000000000000757
crossref_primary_10_1161_CIR_0000000000000638
crossref_primary_10_1161_ATVBAHA_122_318181
crossref_primary_10_1016_j_jacc_2018_11_002
crossref_primary_10_1016_j_jacc_2018_11_003
crossref_primary_10_1016_j_amjcard_2016_08_012
crossref_primary_10_1016_j_jcmg_2016_12_018
crossref_primary_10_1016_j_atherosclerosis_2015_07_033
crossref_primary_10_1161_CIRCGEN_118_001926
crossref_primary_10_1186_s13104_017_2600_2
crossref_primary_10_1007_s11606_019_05361_4
crossref_primary_10_1007_s11936_018_0685_0
crossref_primary_10_1016_j_mayocp_2020_12_039
crossref_primary_10_1093_clinchem_hvac120
crossref_primary_10_1016_j_jacl_2015_11_008
crossref_primary_10_1038_s41598_021_82689_0
crossref_primary_10_1016_j_mcna_2017_03_002
crossref_primary_10_1016_j_ypmed_2016_04_011
crossref_primary_10_3389_fphar_2022_928121
crossref_primary_10_1161_CIRCIMAGING_123_015849
crossref_primary_10_1161_CIRCRESAHA_121_319595
crossref_primary_10_1161_JAHA_120_019589
crossref_primary_10_1016_j_jacadv_2023_100759
crossref_primary_10_1016_j_jacc_2018_11_005
crossref_primary_10_1016_j_jacc_2017_11_007
crossref_primary_10_1186_s40842_016_0024_x
crossref_primary_10_1016_j_cjca_2020_05_007
crossref_primary_10_1016_j_jacl_2015_09_002
crossref_primary_10_1186_s12872_016_0352_x
crossref_primary_10_1186_s12916_015_0351_2
crossref_primary_10_1016_j_jacl_2023_08_005
crossref_primary_10_1097_MOL_0000000000000355
crossref_primary_10_1161_JAHA_117_005627
crossref_primary_10_1111_ene_14155
crossref_primary_10_1016_j_amjmed_2015_08_038
crossref_primary_10_1161_CIRCULATIONAHA_115_018524
crossref_primary_10_1161_JAHA_118_011874
crossref_primary_10_1161_JAHA_120_016115
crossref_primary_10_1111_joim_13176
crossref_primary_10_1007_s11886_019_1175_z
crossref_primary_10_1016_j_jcmg_2018_08_041
crossref_primary_10_1016_j_jacc_2017_02_066
crossref_primary_10_1016_j_jacc_2019_05_045
crossref_primary_10_1016_j_cjca_2020_05_017
crossref_primary_10_1186_s12889_018_5263_6
crossref_primary_10_1016_j_ajpc_2022_100373
crossref_primary_10_1016_j_jacc_2014_06_1185
Cites_doi 10.1016/j.jacc.2013.11.002
10.1016/j.jacc.2013.11.005
10.1001/jama.2012.14306
10.1161/STROKEAHA.111.625277
10.1161/01.cir.0000441139.02102.80
10.1001/jama.2012.13260
10.1111/j.1464-5491.2008.02640.x
10.1111/j.1749-6632.1963.tb13299.x
10.1002/ana.22385
10.1093/oxfordjournals.aje.a112813
10.1001/jama.1990.03450100057025
10.1016/j.ypmed.2008.07.012
10.1161/CIRCULATIONAHA.108.835470
10.1161/STROKEAHA.108.534909
10.1016/1047-2797(91)90005-W
10.1093/oxfordjournals.aje.a115184
10.1016/0895-4356(88)90080-7
10.1161/CIR.0b013e31820faaf8
10.1161/STR.0b013e31825bcdac
ContentType Journal Article
Copyright American College of Cardiology Foundation
2014 American College of Cardiology Foundation
2015 INIST-CNRS
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Copyright Elsevier Limited Sep 9, 2014
Copyright_xml – notice: American College of Cardiology Foundation
– notice: 2014 American College of Cardiology Foundation
– notice: 2015 INIST-CNRS
– notice: Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
– notice: Copyright Elsevier Limited Sep 9, 2014
DBID 6I.
AAFTH
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7TK
H94
K9.
NAPCQ
7X8
DOI 10.1016/j.jacc.2014.06.1186
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
Neurosciences Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Immunology Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

AIDS and Cancer Research Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1558-3597
EndPage 968
ExternalDocumentID 3642013731
10_1016_j_jacc_2014_06_1186
25190228
28779772
S0735109714048177
1_s2_0_S0735109714048177
Genre Journal Article
Comparative Study
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
0SF
18M
1B1
1CY
1P~
1~.
1~5
29L
2WC
3O-
3V.
4.4
457
4G.
53G
5GY
5RE
5VS
6I.
6PF
7-5
71M
7RV
8P~
AABNK
AABVL
AACTN
AAEDT
AAEDW
AAFTH
AAIKJ
AAKUH
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AAXUO
AAYOK
ABBQC
ABFNM
ABFRF
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABVKL
ABXDB
ACGFO
ACGFS
ACIUM
ACJTP
ACPRK
ADBBV
ADEZE
ADMUD
ADVLN
AEFWE
AEKER
AENEX
AEVXI
AEXQZ
AFCTW
AFETI
AFFNX
AFRAH
AFRHN
AFTJW
AGHFR
AGYEJ
AHMBA
AITUG
AJOXV
AJRQY
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AZFZN
BAWUL
BENPR
BLXMC
BPHCQ
CS3
DIK
DU5
E3Z
EBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FNPLU
G-Q
GBLVA
GX1
H13
HVGLF
HX~
HZ~
IHE
IXB
J1W
J5H
K-O
KQ8
L7B
MO0
N4W
N9A
NCXOZ
O-L
O9-
OA.
OAUVE
OK1
OL~
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
QTD
R2-
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SSZ
T5K
TR2
UNMZH
UV1
W8F
WH7
WOQ
WOW
X7M
XPP
YYM
YYP
YZZ
Z5R
ZGI
ZXP
AAIAV
EFLBG
LCYCR
NAHTW
ZA5
08R
ABFLS
ABQIS
ADGIM
IPNFZ
IQODW
PQEST
PQUKI
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7TK
H94
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c517t-19a979477b72b5b379443e350c3eb24b284844656ca5f7f4c7acfdd88a0eb5fd3
IEDL.DBID ABVKL
ISSN 0735-1097
IngestDate Sat Oct 05 05:36:34 EDT 2024
Thu Oct 10 22:46:06 EDT 2024
Thu Sep 12 19:57:05 EDT 2024
Tue Oct 15 23:52:02 EDT 2024
Fri Nov 25 01:03:29 EST 2022
Fri Feb 23 02:32:15 EST 2024
Tue Oct 15 22:52:43 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords SBP
cardiovascular disease
risk assessment
ASCVD
ATP III
Adult Treatment Panel III report
atherosclerotic cardiovascular disease
systolic blood pressure
CVD
HDL-C
National Health and Nutrition Examination Surveys
high-density lipoprotein cholesterol
primary prevention
coronary heart disease
NHANES
risk factors
CHD
Vascular disease
Cohort study
Atherosclerosis
Risk factor
Cardiovascular disease
Risk
Pool
Circulatory system
Cardiology
Public health
Tool
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
CC BY 4.0
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c517t-19a979477b72b5b379443e350c3eb24b284844656ca5f7f4c7acfdd88a0eb5fd3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0735109714048177
PMID 25190228
PQID 1668045272
PQPubID 2031078
PageCount 10
ParticipantIDs proquest_miscellaneous_1560582053
proquest_journals_1668045272
crossref_primary_10_1016_j_jacc_2014_06_1186
pubmed_primary_25190228
pascalfrancis_primary_28779772
elsevier_sciencedirect_doi_10_1016_j_jacc_2014_06_1186
elsevier_clinicalkeyesjournals_1_s2_0_S0735109714048177
PublicationCentury 2000
PublicationDate 2014-09-09
PublicationDateYYYYMMDD 2014-09-09
PublicationDate_xml – month: 09
  year: 2014
  text: 2014-09-09
  day: 09
PublicationDecade 2010
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
– name: New York
PublicationTitle Journal of the American College of Cardiology
PublicationTitleAlternate J Am Coll Cardiol
PublicationYear 2014
Publisher Elsevier Inc
Elsevier
Elsevier Limited
Publisher_xml – name: Elsevier Inc
– name: Elsevier
– name: Elsevier Limited
References Friedman, Cutter, Donahue (bib8) 1988; 41
Carroll, Kit, Lacher, Shero, Mussolino (bib13) 2012; 308
Marma, Lloyd-Jones (bib5) 2009; 120
Lackland, Elkind, D'agostino (bib3) 2012; 43
Howard, Cushman, Kissela (bib18) 2011; 42
Accessed April 21, 2014.
Cavanaugh-Hussey, Berry, Lloyd-Jones (bib4) 2008; 47
Wright, Hughes, Ostchega, Yoon, Nwankwo (bib12) 2011
(bib6) 1989; 129
Kannel, Feinleib, McNamara, Garrison, Castelli (bib10) 1979; 110
Stone, Robinson, Lichtenstein (bib1) 2013; 63
Fried, Borhani, Enright (bib7) 1991; 1
Mosca, Benjamin, Berra (bib14) 2011; 123
Howard, Kleindorfer, Judd (bib16) 2011; 69
Dawber, Kannel, Lyell (bib9) 1963; 107
2013 Prevention Guidelines ASCVD Risk Estimator. Available at
Kittner, White, Losonczy, Wolf, Hebel (bib19) 1990; 264
Kleindorfer (bib20) 2009; 40
Bulugahapitiya, Siyambalapitiya, Sithole, Idris (bib21) 2009; 26
Goff, Lloyd-Jones, Bennett (bib2) 2013; 63
Go, Mozaffarian, Roger (bib15) 2014; 129
Safford, Brown, Muntner (bib17) 2012; 308
25190229 - J Am Coll Cardiol. 2014 Sep 9;64(10):969-70
Stone (10.1016/j.jacc.2014.06.1186_bib1) 2013; 63
Marma (10.1016/j.jacc.2014.06.1186_bib5) 2009; 120
Cavanaugh-Hussey (10.1016/j.jacc.2014.06.1186_bib4) 2008; 47
Fried (10.1016/j.jacc.2014.06.1186_bib7) 1991; 1
10.1016/j.jacc.2014.06.1186_bib11
Wright (10.1016/j.jacc.2014.06.1186_bib12) 2011
(10.1016/j.jacc.2014.06.1186_bib6) 1989; 129
Safford (10.1016/j.jacc.2014.06.1186_bib17) 2012; 308
Friedman (10.1016/j.jacc.2014.06.1186_bib8) 1988; 41
Go (10.1016/j.jacc.2014.06.1186_bib15) 2014; 129
Dawber (10.1016/j.jacc.2014.06.1186_bib9) 1963; 107
Carroll (10.1016/j.jacc.2014.06.1186_bib13) 2012; 308
Lackland (10.1016/j.jacc.2014.06.1186_bib3) 2012; 43
Kannel (10.1016/j.jacc.2014.06.1186_bib10) 1979; 110
Mosca (10.1016/j.jacc.2014.06.1186_bib14) 2011; 123
Howard (10.1016/j.jacc.2014.06.1186_bib16) 2011; 69
Kittner (10.1016/j.jacc.2014.06.1186_bib19) 1990; 264
Goff (10.1016/j.jacc.2014.06.1186_bib2) 2013; 63
Howard (10.1016/j.jacc.2014.06.1186_bib18) 2011; 42
Bulugahapitiya (10.1016/j.jacc.2014.06.1186_bib21) 2009; 26
Kleindorfer (10.1016/j.jacc.2014.06.1186_bib20) 2009; 40
References_xml – volume: 123
  start-page: 1243
  year: 2011
  end-page: 1262
  ident: bib14
  article-title: Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association
  publication-title: Circulation
  contributor:
    fullname: Berra
– volume: 47
  start-page: 619
  year: 2008
  end-page: 623
  ident: bib4
  article-title: Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels In the ATP-III risk assessment tool
  publication-title: Prev Med
  contributor:
    fullname: Lloyd-Jones
– volume: 129
  start-page: 687
  year: 1989
  end-page: 702
  ident: bib6
  article-title: The Atherosclerosis Risk In Communities (ARIC) Study: design and objectives
  publication-title: Am J Epidemiol
– volume: 43
  start-page: 1998
  year: 2012
  end-page: 2027
  ident: bib3
  article-title: Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association
  publication-title: Stroke
  contributor:
    fullname: D'agostino
– volume: 120
  start-page: 384
  year: 2009
  end-page: 390
  ident: bib5
  article-title: Systematic examination of the updated Framingham Heart Study general cardiovascular risk profile
  publication-title: Circulation
  contributor:
    fullname: Lloyd-Jones
– start-page: 1
  year: 2011
  end-page: 22
  ident: bib12
  article-title: Mean systolic and diastolic blood pressure in adults aged 18 and over in the United States, 2001–2008
  publication-title: National Health Statistics Reports
  contributor:
    fullname: Nwankwo
– volume: 1
  start-page: 263
  year: 1991
  end-page: 276
  ident: bib7
  article-title: The Cardiovascular Health Study: design and rationale
  publication-title: Ann Epidemiol
  contributor:
    fullname: Enright
– volume: 26
  start-page: 142
  year: 2009
  end-page: 148
  ident: bib21
  article-title: Is diabetes a coronary risk equivalent? Systematic review and meta-analysis
  publication-title: Diabet Med
  contributor:
    fullname: Idris
– volume: 107
  start-page: 539
  year: 1963
  end-page: 556
  ident: bib9
  article-title: An approach to longitudinal studies in a community: the Framingham study
  publication-title: Ann N Y Acad Sci
  contributor:
    fullname: Lyell
– volume: 42
  start-page: 3369
  year: 2011
  end-page: 3375
  ident: bib18
  article-title: Traditional risk factors as the underlying cause of racial disparities in stroke: lessons from the half-full (empty?) glass
  publication-title: Stroke
  contributor:
    fullname: Kissela
– volume: 41
  start-page: 1105
  year: 1988
  end-page: 1116
  ident: bib8
  article-title: CARDIA: study design, recruitment, and some characteristics of the examined subjects
  publication-title: J Clin Epidemiol
  contributor:
    fullname: Donahue
– volume: 264
  start-page: 1267
  year: 1990
  end-page: 1270
  ident: bib19
  article-title: Black-white differences in stroke incidence in a national sample. The contribution of hypertension and diabetes mellitus
  publication-title: JAMA
  contributor:
    fullname: Hebel
– volume: 110
  start-page: 281
  year: 1979
  end-page: 290
  ident: bib10
  article-title: An investigation of coronary heart disease in families. The Framingham offspring study
  publication-title: Am J Epidemiol
  contributor:
    fullname: Castelli
– volume: 40
  start-page: S75
  year: 2009
  end-page: S78
  ident: bib20
  article-title: Sociodemographic groups at risk: race/ethnicity
  publication-title: Stroke
  contributor:
    fullname: Kleindorfer
– volume: 63
  start-page: 2935
  year: 2013
  end-page: 2959
  ident: bib2
  article-title: 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Bennett
– volume: 308
  start-page: 1545
  year: 2012
  end-page: 1554
  ident: bib13
  article-title: Trends in lipids and lipoproteins in US adults, 1988–2010
  publication-title: JAMA
  contributor:
    fullname: Mussolino
– volume: 308
  start-page: 1768
  year: 2012
  end-page: 1774
  ident: bib17
  article-title: Association of race and sex with risk of incident acute coronary heart disease events
  publication-title: JAMA
  contributor:
    fullname: Muntner
– volume: 63
  start-page: 2889
  year: 2013
  end-page: 2934
  ident: bib1
  article-title: 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
  publication-title: J Am Coll Cardiol
  contributor:
    fullname: Lichtenstein
– volume: 69
  start-page: 619
  year: 2011
  end-page: 627
  ident: bib16
  article-title: Disparities in stroke incidence contributing to disparities in stroke mortality
  publication-title: Ann Neurol
  contributor:
    fullname: Judd
– volume: 129
  start-page: E28
  year: 2014
  end-page: E292
  ident: bib15
  article-title: Heart disease and stroke statistics–2014 update: a report from the American Heart Association
  publication-title: Circulation
  contributor:
    fullname: Roger
– volume: 63
  start-page: 2889
  year: 2013
  ident: 10.1016/j.jacc.2014.06.1186_bib1
  article-title: 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2013.11.002
  contributor:
    fullname: Stone
– volume: 63
  start-page: 2935
  year: 2013
  ident: 10.1016/j.jacc.2014.06.1186_bib2
  article-title: 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2013.11.005
  contributor:
    fullname: Goff
– volume: 308
  start-page: 1768
  year: 2012
  ident: 10.1016/j.jacc.2014.06.1186_bib17
  article-title: Association of race and sex with risk of incident acute coronary heart disease events
  publication-title: JAMA
  doi: 10.1001/jama.2012.14306
  contributor:
    fullname: Safford
– ident: 10.1016/j.jacc.2014.06.1186_bib11
– volume: 42
  start-page: 3369
  year: 2011
  ident: 10.1016/j.jacc.2014.06.1186_bib18
  article-title: Traditional risk factors as the underlying cause of racial disparities in stroke: lessons from the half-full (empty?) glass
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.111.625277
  contributor:
    fullname: Howard
– volume: 129
  start-page: E28
  year: 2014
  ident: 10.1016/j.jacc.2014.06.1186_bib15
  article-title: Heart disease and stroke statistics–2014 update: a report from the American Heart Association
  publication-title: Circulation
  doi: 10.1161/01.cir.0000441139.02102.80
  contributor:
    fullname: Go
– volume: 308
  start-page: 1545
  year: 2012
  ident: 10.1016/j.jacc.2014.06.1186_bib13
  article-title: Trends in lipids and lipoproteins in US adults, 1988–2010
  publication-title: JAMA
  doi: 10.1001/jama.2012.13260
  contributor:
    fullname: Carroll
– volume: 26
  start-page: 142
  year: 2009
  ident: 10.1016/j.jacc.2014.06.1186_bib21
  article-title: Is diabetes a coronary risk equivalent? Systematic review and meta-analysis
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.2008.02640.x
  contributor:
    fullname: Bulugahapitiya
– volume: 107
  start-page: 539
  year: 1963
  ident: 10.1016/j.jacc.2014.06.1186_bib9
  article-title: An approach to longitudinal studies in a community: the Framingham study
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.1963.tb13299.x
  contributor:
    fullname: Dawber
– volume: 69
  start-page: 619
  year: 2011
  ident: 10.1016/j.jacc.2014.06.1186_bib16
  article-title: Disparities in stroke incidence contributing to disparities in stroke mortality
  publication-title: Ann Neurol
  doi: 10.1002/ana.22385
  contributor:
    fullname: Howard
– volume: 110
  start-page: 281
  year: 1979
  ident: 10.1016/j.jacc.2014.06.1186_bib10
  article-title: An investigation of coronary heart disease in families. The Framingham offspring study
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a112813
  contributor:
    fullname: Kannel
– volume: 264
  start-page: 1267
  year: 1990
  ident: 10.1016/j.jacc.2014.06.1186_bib19
  article-title: Black-white differences in stroke incidence in a national sample. The contribution of hypertension and diabetes mellitus
  publication-title: JAMA
  doi: 10.1001/jama.1990.03450100057025
  contributor:
    fullname: Kittner
– volume: 47
  start-page: 619
  year: 2008
  ident: 10.1016/j.jacc.2014.06.1186_bib4
  article-title: Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels In the ATP-III risk assessment tool
  publication-title: Prev Med
  doi: 10.1016/j.ypmed.2008.07.012
  contributor:
    fullname: Cavanaugh-Hussey
– start-page: 1
  year: 2011
  ident: 10.1016/j.jacc.2014.06.1186_bib12
  article-title: Mean systolic and diastolic blood pressure in adults aged 18 and over in the United States, 2001–2008
  publication-title: National Health Statistics Reports
  contributor:
    fullname: Wright
– volume: 120
  start-page: 384
  year: 2009
  ident: 10.1016/j.jacc.2014.06.1186_bib5
  article-title: Systematic examination of the updated Framingham Heart Study general cardiovascular risk profile
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.108.835470
  contributor:
    fullname: Marma
– volume: 40
  start-page: S75
  year: 2009
  ident: 10.1016/j.jacc.2014.06.1186_bib20
  article-title: Sociodemographic groups at risk: race/ethnicity
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.108.534909
  contributor:
    fullname: Kleindorfer
– volume: 1
  start-page: 263
  year: 1991
  ident: 10.1016/j.jacc.2014.06.1186_bib7
  article-title: The Cardiovascular Health Study: design and rationale
  publication-title: Ann Epidemiol
  doi: 10.1016/1047-2797(91)90005-W
  contributor:
    fullname: Fried
– volume: 129
  start-page: 687
  year: 1989
  ident: 10.1016/j.jacc.2014.06.1186_bib6
  article-title: The Atherosclerosis Risk In Communities (ARIC) Study: design and objectives
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a115184
– volume: 41
  start-page: 1105
  year: 1988
  ident: 10.1016/j.jacc.2014.06.1186_bib8
  article-title: CARDIA: study design, recruitment, and some characteristics of the examined subjects
  publication-title: J Clin Epidemiol
  doi: 10.1016/0895-4356(88)90080-7
  contributor:
    fullname: Friedman
– volume: 123
  start-page: 1243
  year: 2011
  ident: 10.1016/j.jacc.2014.06.1186_bib14
  article-title: Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association
  publication-title: Circulation
  doi: 10.1161/CIR.0b013e31820faaf8
  contributor:
    fullname: Mosca
– volume: 43
  start-page: 1998
  year: 2012
  ident: 10.1016/j.jacc.2014.06.1186_bib3
  article-title: Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association
  publication-title: Stroke
  doi: 10.1161/STR.0b013e31825bcdac
  contributor:
    fullname: Lackland
SSID ssj0006819
Score 2.5579538
Snippet Abstract Background The 2013 American College of Cardiology/American Heart Association updated cholesterol guidelines recommend the use of Pooled Cohort...
The 2013 American College of Cardiology/American Heart Association updated cholesterol guidelines recommend the use of Pooled Cohort Equations to estimate...
Background The 2013 American College of Cardiology/American Heart Association updated cholesterol guidelines recommend the use of Pooled Cohort Equations to...
BACKGROUNDThe 2013 American College of Cardiology/American Heart Association updated cholesterol guidelines recommend the use of Pooled Cohort Equations to...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 959
SubjectTerms Adult
African Americans
Age Distribution
Aged
American Heart Association
Atherosclerosis (general aspects, experimental research)
Atherosclerosis - drug therapy
Atherosclerosis - epidemiology
Atherosclerosis - prevention & control
Biological and medical sciences
Blood and lymphatic vessels
Cardiology
Cardiology. Vascular system
Cardiovascular
Cardiovascular disease
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - prevention & control
Cholesterol
Cohort Studies
Diabetes Mellitus - epidemiology
Diabetes Mellitus - prevention & control
Drug therapy
Female
Health risk assessment
Heart
Heart attacks
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Hypercholesterolemia - epidemiology
Hypercholesterolemia - prevention & control
Internal Medicine
Male
Medical sciences
Middle Aged
Multivariate Analysis
Practice Guidelines as Topic - standards
Predictive Value of Tests
Prevalence
primary prevention
Primary Prevention - standards
Proportional Hazards Models
Risk Assessment
Risk Factors
risk factors
Sex Distribution
Smoking - epidemiology
Smoking Prevention
United States - epidemiology
Title A Systematic Examination of the 2013 ACC/AHA Pooled Cohort Risk Assessment Tool for Atherosclerotic Cardiovascular Disease
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0735109714048177
https://dx.doi.org/10.1016/j.jacc.2014.06.1186
https://www.ncbi.nlm.nih.gov/pubmed/25190228
https://www.proquest.com/docview/1668045272
https://search.proquest.com/docview/1560582053
Volume 64
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbarYSQKsSbhbIyEkfCxokTO8c0tFoeRYi2aG-W7dhiS7VZNVuJC_yW_pb-MmbyqlaoHLglmSQeecbjz5rxZ0Jeh6lhwjgTOF9GAWehDqQ2WeBtohNrtGEW9zsffU5np_zDPJlvkaLfC4NllV3sb2N6E627J9OuN6erxWJ6DM6ZYP4UCWIkE2Kb7ESYZhqRnXz_28dPQ0BOZXO-B74f4Ac9-VBT5nWmLTIZMo40noC209smqN2VrqHbfHvexe2AtJmYDu-Tex2ipHmr9AOy5ZYPyZ2jLmf-iPzK6fFA10wPfmosfkFz0MpTgH8U1Iqvr_KimOaznH6pqnNX0qL6DsCcfl3UP0A20HfSExBTALo0R-RY1dDkRQU_vr4qNipb6bs28_OYnB4enBSzoDt0IbAJE-uAZTqDMSqEEZFJTAzXPHZxEtoYFuHcwHQmG5I1qxMvPLdCW1-WUurQmcSX8RMyWlZL94xQB9iGZ2mmvRfc-ljyMnUy5jo2JZNejsmbvqfVquXWUH3R2ZlCwyg0jApThYYZE9FbQ_XbRiHQubobdbViqo5UqP7yjDFJhy83nEvBvPHvJicbVh_UhHWmAOQcjcle7wbqRo00lchUj-JXgxiGLeZi9NJVl_BOgvnoCELgmDxt3efm54CqkZbo-f-q_YLcxdumFC7bI6P1xaV7CdhpbSZk--1vNulGCNy9n-__AcVZGpY
link.rule.ids 315,786,790,3525,4521,27600,27955,27956,45618,45696,45907
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkQAJId4ESjESR6LNw68cQ2i1QLdCdCvtzbITW2xBm1WzlbjwX_pb-suYyataoXLgFmUcZ-QZjz9rxp8JeRcJG0vrbOh8lYQsjkyojM1CX3LDS2tsXOJ559mxmJ6yzwu-2CHFcBYGyyr72N_F9DZa928m_WhO1svl5ASck2P-FAliVCzlLXKbcdjr4Sm-xYcxHAvV3u6BrUNsPlAPtUVeZ6ZEHsOYIYknYG1x0_J0f20aGDTf3XZxMxxtl6XDh-RBjydp3qn8iOy41WNyZ9ZnzJ-Q3zk9Gcma6cEvg6UvaAxaewrgj4Ja6dVlXhSTfJrTr3X901W0qL8DLKffls0PkI3knXQOYgowl-aIG-sGfnleQ8dXl8VWXSv92OV9npLTw4N5MQ37KxfCksdyE8aZyWCGSmllYrlN4ZmlLuVRmcIWnFlYzFRLsVYa7qVnpTSlryqlTOQs91X6jOyu6pV7QagDZMMykRnvJSt9qlglnEqZSW0VK68C8n4Yab3umDX0UHJ2ptEwGg2jI6HRMAGRgzX0cGgUwpxr-jnX6Fg3iY70X34REDF-ueVaGlaNf_9yf8vqo5qwy5SAm5OA7A1uoK_VEEIhTz2K345imLSYiTErV19AG47Z6AQCYECed-5z3TlgaiQlevm_ar8hd6fz2ZE--nT85RW5h6K2KC7bI7ub8wv3GlDUxu63s-QPtLEaag
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Systematic+Examination+of+the+2013%C2%A0ACC%2FAHA+Pooled+Cohort+Risk%C2%A0Assessment+Tool+for+Atherosclerotic%C2%A0Cardiovascular+Disease&rft.jtitle=Journal+of+the+American+College+of+Cardiology&rft.au=Karmali%2C+Kunal+N.&rft.au=Goff%2C+David+C.&rft.au=Ning%2C+Hongyan&rft.au=Lloyd-Jones%2C+Donald+M.&rft.date=2014-09-09&rft.issn=0735-1097&rft.volume=64&rft.issue=10&rft.spage=959&rft.epage=968&rft_id=info:doi/10.1016%2Fj.jacc.2014.06.1186&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jacc_2014_06_1186
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F07351097%2FS0735109714X00392%2Fcov150h.gif